Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Castration Resistant Prostate Cancer × Triamcinolone Acetonide × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Radiodermatitis 1 Lymphomatoid Papulosis 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Lichen Planus, Oral 1 Leiomyoma 1 Disease 1 Castration Resistant Prostate Cancer 1 Breast Neoplasms 1 Adenomyosis 1

Interventions

Triamcinolone Acetonide 1 TH 302 1 Specimen Handling 1 Magnetic Resonance Spectroscopy 1 Injections, Intramuscular 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07161778 2025-09-09

TRICREST

Barts & The London NHS Trust

Phase 2 Completed

Castration Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡